Global Preterm Birth and PROM Testing Market to Reach US$ 2.6 Billion by 2032, Stimulated by Advancements In Diagnostic Technologies

September 08, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Preterm Birth and PROM Testing Market Report by Test Type (Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitrazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), and Others), Application (PROM, Preterm Labor, Chorioamnionitis), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032,” the global preterm birth and PROM testing market size reached US$ 1.7 Billion in 2023. Preterm birth and premature rupture of membranes (PROM) testing are critical medical assessments that help identify and manage pregnancy-related complications. Preterm birth refers to the delivery of a baby 37 weeks before gestation, which can lead to various health issues for the infant. PROM occurs when the amniotic sac surrounding the fetus ruptures before the onset of labor. These conditions demand timely detection and intervention to ensure the best outcomes for the mother and baby. Preterm birth and PROM tests enable healthcare providers to assess a woman's risk of preterm birth or PROM, allowing for early intervention and preventive measures. They aid in confirming the diagnosis when symptoms like premature contractions or leaking amniotic fluid are present. It can guide medical professionals in making informed decisions about the timing and method of delivery to optimize the health of both mother and baby. Preterm birth and PROM testing are pivotal in reducing the risks associated with premature birth and enhancing the well-being of expectant mothers and their infants.

Global Preterm Birth and PROM Testing Market Trends:

The increasing awareness among healthcare providers and expectant mothers about the significance of early detection and proactive management of preterm birth risks are major factors contributing to the market growth. Moreover, rapid advancements in medical technology, such as precision diagnostics in the field of obstetrics and growing innovations in biomarker research, are positively impacting the market growth. In line with this, the development of non-invasive diagnostic tools empowering healthcare professionals with accurate and accessible means of assessing preterm birth and PROM risks is providing a considerable boost to the market growth. These technological advancements stream the testing process and improve diagnostic accuracy, ultimately favoring the market's growth. Additionally, the increasing prevalence of lifestyle-related risk factors, such as stress and poor nutrition, linking to an elevated risk of preterm birth and PROM and prompting a greater emphasis on early testing and preventive interventions, is providing a thrust to the market growth. Furthermore, the rising collaborations between healthcare institutions and pharmaceutical companies facilitating the development of novel diagnostic solutions are providing remunerative growth opportunities for the market. Looking forward, the market value is projected to reach US$ 2.6 Billion by 2032, expanding at a CAGR of 5% during 2024-2032.

Market Summary:

  • Based on the test type, the market has been segmented into pelvic exam, ultrasound, biochemical markers [interleukin (IL)-6, C-reactive protein (CRP), IL-1, IL-2, IL-8, TNF-a, corticotropin-releasing hormone (CRH), and alpha-fetoprotein (AFP], uterine monitoring, nitrazine test, ferning test, pooling, PAMG-1 immunoassay, IGFBP test, fetal fibronectin (fFN), and others. According to the report, ultrasound represents the largest segment.
  • On the basis of the application, the market has been divided into PROM, preterm labor, and chorioamnionitis. Among these, preterm labor represents the largest segment.
  • Based on the end user, the market has been classified into hospitals, diagnostic laboratories, and others. According to the report, hospitals represent the largest segment.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. Among these, North America is the leading market, accounting for the majority of the global share.
  • The competitive landscape of the market has also been examined, with some of the key players being Clinical Innovations LLC (Laborie Medical Technologies Inc.), Cooper Surgical Inc. (The Cooper Companies Inc.), Hologic Inc., IQ Products, NX Prenatal Inc., Qiagen N.V, Sera Prognostics, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Test Type
  • Application
  • End User
  • Region 
Test Types Covered
  • Pelvic Exam
  • Ultrasound
  • Biochemical Markers: Interleukin (IL)-6, C-Reactive Protein (CRP), IL-1, IL-2, IL-8, TNF-a, Corticotropin-Releasing Hormone (CRH), Alpha-fetoprotein (AFP)
  • Uterine Monitoring
  • Nitrazine Test
  • Ferning Test
  • Pooling
  • PAMG-1 Immunoassay
  • IGFBP Test
  • Fetal Fibronectin (fFN)
  • Others 
Applications Covered PROM, Preterm Labor, Chorioamnionitis
End Users Covered Hospitals, Diagnostic Laboratories, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Clinical Innovations LLC (Laborie Medical Technologies Inc.), Cooper Surgical Inc. (The Cooper Companies Inc.), Hologic Inc., IQ Products, NX Prenatal Inc., Qiagen N.V, Sera Prognostics, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Preterm Birth and PROM Testing Market to Reach US$ 2.6 Billion by 2032, Stimulated by Advancements In Diagnostic Technologies
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More